TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

BIO-THERA SOLUTIONS LTD

OncologyImmunologyOphthalmology
Biotech

BIO-THERA SOLUTIONS LTD is a biotechnology company focused on Oncology, Immunology, Ophthalmology.

2023
Since
2
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 45%
1 drugs Phase 3: 2 Phase 2: 2 Phase 1: 17
Immunology 35%
1 drugs Phase 3: 4 Phase 1: 5
Ophthalmology 10%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 2
Gastroenterology 8%
1 drugs
Dermatology 1%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...